ABC | Volume 114, Nº6, June 2020

Original Article Yang et al Chemotherapy-related coronary-artery disease Arq Bras Cardiol. 2020; 114(6):1004-1012 1. Curigliano G, Cardinale D, Dent S, Criscitiello C, Aseyev O, Lenihan D, et al. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management. CA Cancer J Clin. 2016;66(4):309-25. 2. Curigliano G, Cardinale D, Suter T, Plataniotis G, de Azambuja E, Sandri MT, et al. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMOClinical Practice Guidelines. AnnOncol. 2012;23 Suppl 7:vii155-66. 3. Zerna C, Guenther M, Folprecht G, Puetz V. Acute ischaemic stroke and myocardial infarction after chemotherapy with vinorelbine for non-small cell lung cancer: a case report. J Chemother. 2017;29(1):49-53. 4. Suh KJ, Lee JY, Shin DY, Koh Y, Bang SM, Yoon SS, et al. Analysis of adverse events associated with dasatinib and nilotinib treatments in chronic-phase chronic myeloid leukemia patients outside clinical trials. Int J Hematol. 2017;106(2):229-39. 5. Chang HM, Moudgil R, Scarabelli T, Okwuosa TM, Yeh ETH. Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 1. J Am Coll Cardiol .2017;70(20):2536-51. 6. Bertolini A, Flumanò M, Fusco O, Muffatti A, Scarinci A, Pontiggia G, et al. Acute cardiotoxicity during capecitabine treatment: a case report. Tumori. 2001;87(3):200-6. 7. Shoemaker L, Arora U, Rocha Lima C. 5-fluorouracil-induced coronary vasospasm. Cancer Control .2004;11(1):46-9. 8. Rao AS, Kumar R, Narayanan GS. A rare case of cisplatin-induced acute myocardial infarction in a patient receiving chemoradiation for lung cancer. J Cancer Res Ther. 2015;11(4):983-5. 9. ChenW, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115-32. 10. Pilkington G, Boland A, Brown T, Oyee J, Bagust A, Dickson R. A systematic review of the clinical effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer. Thorax. 2015;70(4):359-67. 11. Du L, Morgensztern D. Chemotherapy for Advanced-Stage Non-Small Cell Lung Cancer. Cancer J .2015;21(5):366-70. 12. Roy A, Khanna N, Senguttuvan NB. Rituximab-vincristine chemotherapy- induced acute anterior wall myocardial infarction with cardiogenic shock. Tex Heart Inst J. 2014;41(1):80-2. 13. van Gaal WJ, Ponnuthurai FA, Selvanayagam J, Testa L, Porto I, Neubauer S, et al. The Syntax score predicts peri-procedural myocardial necrosis during percutaneous coronary intervention. Int J Cardiol. 2009;135(1):60-5. 14. Ellis SG, Roubin GS, King SB, 3rd, Douglas JS, Jr., Weintraub WS, Thomas RG, et al. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation .1988;77(2):372-9. 15. Ekici B, Kutuk U, Alhan A, Tore HF. The relationship between serum uric acid levels and angiographic severity of coronary heart disease. Kardiol Pol .2015;73(7):533-8. 16. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1(2):219-27. 17. Wykrzykowska JJ, Garg S, Girasis C, de Vries T, Morel MA, van Es GA, et al. Value of the SYNTAX score for risk assessment in the all-comers population of the randomizedmulticenter LEADERS (Limus Eluted fromADurable versus ERodable Stent coating) trial. J Am Coll Cardiol. 2010;56(4):272-7. 18. Stone GW, Sabik JF, Serruys PW, Simonton CA, Genereux P, Puskas J, et al. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease. N Engl J Med. 2016;375(23):2223-35. 19. Girasis C, Garg S, Raber L, Sarno G, Morel MA, Garcia-Garcia HM, et al. SYNTAX score and Clinical SYNTAX score as predictors of very long- term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial. Eur Heart J. 2011;32(24):3115-27. 20. Hu S, Gao H, Zhang J, Han X, Yang Q, Zhang J, et al. Association between Radiotherapy and Anatomic Severity of Coronary Artery Disease: A Propensity Score Matching Comparison Among Adult-Onset Thoracic Cancer Survivors. Cardiology. 2018;140(4):239-46. 21. Reed GW, Rossi JE, Masri A, Griffin BP, Ellis SG, Kapadia SR, et al. Angiographic predictors of adverse outcomes after percutaneous coronary intervention in patients with radiation associated coronary artery disease. Catheter Cardiovasc Interv. 2019;94(3):E104-E110. 22. Serruys PW,MoriceMC, KappeteinAP, ColomboA, Holmes DR,MackMJ, et al.Percutaneouscoronary interventionversuscoronary-arterybypassgrafting for severe coronary artery disease. N Engl J Med .2009;360(10):961-72. 23. Yeh ET, Tong AT, Lenihan DJ, Yusuf SW, Swafford J, Champion C, et al. Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation. 2004;109(25):3122-31. 24. Chavez-MacGregor M, Zhang N, Buchholz TA, Zhang Y, Niu J, Elting L, et al. Trastuzumab-related cardiotoxicity among older patients with breast cancer. J Clin Oncol. 2013;31(33):4222-8. 25. Giza DE, Iliescu G, Hassan S, Marmagkiolis K, Iliescu C. Cancer as a Risk Factor for Cardiovascular Disease. Curr Oncol Rep. 2017;19(6):39. 26. Haugnes HS, Wethal T, Aass N, Dahl O, Klepp O, Langberg CW, et al. Cardiovascular risk factors andmorbidity in long-term survivors of testicular cancer: a 20-year follow-up study. J Clin Oncol. 2010;28(30):4649-57. 27. RossiA,TayR,Chiramel J,PrelajA,CalifanoR.Currentand futuretherapeutic approaches for the treatment of small cell lung cancer. Expert Rev Anticancer Ther. 2018;18(5):473-86. 28. Hu S, Chen Y, Li L, Chen J, Wu B, Zhou X, et al. Effects of adenovirus- mediated delivery of the human hepatocyte growth factor gene in experimental radiation-induced heart disease. Int J Radiat Oncol Biol Phys. 2009;75(5):1537-44. 29. Kupeli S, Hazirolan T, Varan A, Akata D, Alehan D, HayranM, et al. Evaluation of coronary artery disease by computed tomography angiography in patients treatedforchildhoodHodgkin’slymphoma.JClinOncol.2010;28(6):1025-30. .30. van Rosendael AR, Daniels LA, Dimitriu-Leen AC, Smit JM, van Rosendael PJ, Schalij MJ, et al. Different manifestation of irradiation induced coronary arterydiseasedetectedwithcoronarycomputedtomographycomparedwith matched non-irradiated controls. Radiother Oncol. 2017;125(1):55-61. 31. Brezinka V, Padmos I. Coronary heart disease risk factors in women. Eur Heart J. 1994;15(11):1571-84. 32. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099whitemen. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med. 1992;152(1):56-64. 33. Adams KF, Schatzkin A, Harris TB, Kipnis V, MouwT, Ballard-Barbash R, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006;355(8):763-78. 34. Barthelemy O, Jacqueminet S, Rouzet F, Isnard R, Bouzamondo A, Le GuludecD,etal. Intensivecardiovascularrisk factorstherapyandprevalence of silent myocardial ischaemia in patients with type 2 diabetes. Arch Cardiovasc Dis. 2008;101(9):539-46. 35. Jaumdally JR, Lip GY, Varma C. Traditional risk factors for coronary atherosclerosis in Indo Asians: the need for a reappraisal. Curr Pharm Des 2006;12(13):1611-21. 36. Li Y, Shi J, Yu S, Wang L, Liu J, Ren J, et al. Effect of socioeconomic status on stage at diagnosis of lung cancer in a hospital-based multicenter retrospective clinical epidemiological study in China, 2005-2014. Cancer Med 2017;6(10):2440-2452. References 1011